Feb 13, 2025 07:45PM
Dec 18, 2024 01:30PM
Sep 17, 2024 05:00PM
Mar 22, 2024 09:37AM
Mar 22, 2024 09:36AM
Mar 21, 2024 07:30AM
Aug 30, 2023 10:34AM Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide
Jun 12, 2023 07:30AM
Jun 2, 2023 12:15PM
May 25, 2023 05:31PM
May 9, 2023 12:01PM
Apr 18, 2023 09:00AM
Apr 12, 2023 07:30AM
Mar 14, 2023 06:42PM Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
Feb 28, 2023 07:30AM
Feb 28, 2023 06:30AM
Feb 16, 2023 07:30AM
Jan 4, 2023 07:45AM
Dec 1, 2022 06:30PM
Oct 26, 2022 07:30AM
Oct 13, 2022 07:30AM Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update
Oct 3, 2022 03:09PM
Sep 12, 2022 07:30AM
Jul 28, 2022 11:19AM
Jul 14, 2022 07:30AM
Jul 14, 2022 06:30AM
Jul 13, 2022 07:40AM
May 31, 2022 07:32AM Theratechnologies Announces New Head of Investor Relations
May 10, 2022 10:47AM
Apr 27, 2022 07:30AM
Apr 27, 2022 07:30AM
Apr 13, 2022 07:30AM
Feb 24, 2022 07:30AM
Feb 16, 2022 07:30AM
Feb 15, 2022 07:30AM Theratechnologies Strengthens Global Commercial Capabilities by Launching Internal Field Force
Dec 6, 2021 11:52AM
Oct 26, 2021 02:00AM
Oct 22, 2021 09:16AM
Oct 22, 2021 09:15AM
Oct 13, 2021 07:00AM
Sep 22, 2021 08:08AM
Aug 13, 2021 09:08AM Theratechnologies Announces Publication of TH1902 Preclinical Data in Peer-Reviewed Journal, Cancer Science
Jul 15, 2021 07:00AM
Jun 21, 2021 09:00AM
Jun 21, 2021 09:00AM
Jun 10, 2021 04:01PM
Apr 14, 2021 07:30AM
Apr 10, 2021 10:02AM
Mar 24, 2021 07:30AM Theratechnologies annonce l’administration du TH1902 au premier patient dans l’essai clinique de phase 1 pour le traitement des tumeurs solides exprimant le récepteur de la sortiline
Mar 20, 2021 11:00AM

322,260 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All